CRT 2023
Evening Symposium: Equality, Diversity and Inclusion: Addressing Inequalities in Interventional Cardiology and Healthcare
Joaquin E. Cigarroa, MD
Head of the Division of Cardiovascular Medicine
OHSU Knight Cardiovascular Institute
Portland, Oregon, United States
No relationships to disclose
Rebecca Torguson, MPH
Deputy Division Director
FDA
Washington, District of Columbia, United States
No relationships to disclose
Karol Watson, MD, PhD
Attending Cardiologist
Ronald Reagan UCLA Medical Center
David Geffen School of Medicine at UCLA
Redondo Beach, California, United States
Disclosure(s): Amarin: Consultant (Ongoing); Amgen: Consultant (Ongoing); Boehringer Ingelheim: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Ongoing)
Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC
Chair, Department of Medicine
University of Louisville
Louisville, Kentucky, United States
No relationships to disclose
Wayne Batchelor, MD, MHS
Director, Interventional Cardiology and Interventional Research and Innovation
Inova Heart & Vascular Institute
Falls Church, Virginia, United States
Disclosure(s): Abbott: Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Idorsia Pharmaceuticals: Clinical Trial Support (Ongoing), Consultant (Ongoing); Medtronic Cardiovascular: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); V Wave: Consultant (Ongoing)
Brian C. Case, MD
Interventional Cardiologist
MedStar Heart and Vascular Institute
Bethesda, Maryland, United States
Disclosure(s): No financial relationships to disclose
Cara Hendry, MD FRCP LLM
Consultant Cardiologist
Manchester University NHS Foundation Trust
Bolton , England, United Kingdom
Disclosure(s): No financial relationships to disclose
Aaron Horne, Jr., MD, MBA
Structural Interventionalist
Summit Health
Berkeley Heights, New Jersey, United States
Disclosure(s): No financial relationships to disclose
Ankur Kalra, MD (he/him/his)
Interventional Cardiologist
Franciscan Health, United States
Disclosure information not submitted.
Spencer B. King, III, MD, MACC, MSCAI
Professor of Medicine Emeritus
Emory University
Atlanta, Georgia, United States
No relationships to disclose
David F. Kong, MD, AM, DMT (he/him/his)
Associate Professor of Medicine
Duke University
Durham, North Carolina, United States
Disclosure(s): Medtronic: University Grants/Research Support (Ongoing); Philips: University Grants/Research Support (Ongoing)
Seth S. Martin, MD, MHS, FACC, FAHA, FASPC
Associate Professor
Johns Hopkins
Reisterstown, Maryland, United States
Disclosure(s): Amgen, Sanofi/Regeneron, Esperion, Novo Nordisk, Akcea: Scientific Advisory Board (Ongoing); Novartis Pharmaceuticals: Scientific Advisory Board (Ongoing)
Michael J. Rinaldi, MD
Director Structural Heart Program
Sanger Heart and Vascular Institute/Atrium Health
Charlotte, North Carolina, United States
Disclosure(s): Abbott Vascular: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences LLC: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Scientific Advisory Board (Ongoing)
Ido Weinberg, MD
Medical Director
Massachusetts General Hospital
Boston, Massachusetts, United States
Disclosure(s): Magneto: Consultant (Ongoing); Penumbra, Inc.: Clinical Trial Investigator (Ongoing), Consultant (Ongoing)
Roseann M. White, MA
Senior Director of Biostatistics
Edwards Lifesciences
Chapel Hill, North Carolina, United States
Disclosure(s): Edwards Lifesciences: Employee (Ongoing)